首页 > 最新文献

Minimally Invasive Therapy & Allied Technologies最新文献

英文 中文
Advancing apical POP treatment: a comparative analysis of vNOTES lateral suspension and laparoscopic lateral suspension. 推进根尖POP治疗:vNOTES外侧悬吊与腹腔镜外侧悬吊的比较分析。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-07-26 DOI: 10.1080/13645706.2025.2532108
Gizem Berfin Uluutku Bulutlar, Eralp Bulutlar, Ayşe Betül Albayrak Denizli, Çetin Kılıççı

Background: Apical pelvic organ prolapse (POP) significantly impacts quality of life. The vaginal natural orifice transluminal endoscopic surgery lateral suspension (vNOTES LS) combines the benefits of vNOTES and mesh-based suspension. This study compares clinical outcomes of vNOTES LS and laparoscopic lateral suspension (LLS) in patients with ≥ Stage 3 apical POP.

Methods: In this retrospective cohort study, 80 patients with ≥ Stage 3 apical and/or anterior wall defects underwent hysterectomy with vNOTES LS (n = 40) or LLS (n = 40) between January 2022 and January 2024. Perioperative parameters, postoperative outcomes, and POP-Q measurements (Ba and C) were analyzed.

Results: Preoperative characteristics, including BMI and prolapse stage, were comparable. Postoperative POP-Q measurements (Ba and C) significantly improved in the vNOTES LS group at day 1, month 6, and year 1 (p < 0.05). Operative time and hematocrit changes were similar (p > 0.05). Hospital stay was shorter with vNOTES LS (1.05 ± 0.22 vs. 2.2 ± 0.75 days, p < 0.05), and fewer complications were noted. No urinary injury, mesh erosion, or recurrence occurred in the vNOTES LS group.

Conclusions: vNOTES LS demonstrated comparable success to LLS with shorter hospital stays and fewer complications. Its minimally invasive nature highlights its potential as a promising alternative for selected patients.

背景:根尖盆腔器官脱垂(POP)显著影响患者的生活质量。阴道自然孔腔内窥镜手术侧悬架(vNOTES LS)结合了vNOTES和基于网格的悬架的优点。本研究比较了vNOTES LS和腹腔镜侧悬挂(LLS)治疗≥3期根尖POP患者的临床结果。方法:在这项回顾性队列研究中,80例≥3期根尖和/或前壁缺陷患者在2022年1月至2024年1月期间采用vNOTES LS (n = 40)或LLS (n = 40)进行子宫切除术。分析围手术期参数、术后结果和POP-Q测量值(Ba和C)。结果:术前特征,包括BMI和脱垂阶段,具有可比性。vNOTES LS组术后第1天、第6个月和第1年的POP-Q测量值(Ba和C)显著改善(p < 0.05)。vNOTES LS的住院时间较短(1.05±0.22天和2.2±0.75天,p)。结论:vNOTES LS与LLS相比,住院时间较短,并发症较少。它的微创性突出了它作为一种有希望的替代选择的潜力。
{"title":"Advancing apical POP treatment: a comparative analysis of vNOTES lateral suspension and laparoscopic lateral suspension.","authors":"Gizem Berfin Uluutku Bulutlar, Eralp Bulutlar, Ayşe Betül Albayrak Denizli, Çetin Kılıççı","doi":"10.1080/13645706.2025.2532108","DOIUrl":"https://doi.org/10.1080/13645706.2025.2532108","url":null,"abstract":"<p><strong>Background: </strong>Apical pelvic organ prolapse (POP) significantly impacts quality of life. The vaginal natural orifice transluminal endoscopic surgery lateral suspension (vNOTES LS) combines the benefits of vNOTES and mesh-based suspension. This study compares clinical outcomes of vNOTES LS and laparoscopic lateral suspension (LLS) in patients with ≥ Stage 3 apical POP.</p><p><strong>Methods: </strong>In this retrospective cohort study, 80 patients with ≥ Stage 3 apical and/or anterior wall defects underwent hysterectomy with vNOTES LS (<i>n</i> = 40) or LLS (<i>n</i> = 40) between January 2022 and January 2024. Perioperative parameters, postoperative outcomes, and POP-Q measurements (Ba and C) were analyzed.</p><p><strong>Results: </strong>Preoperative characteristics, including BMI and prolapse stage, were comparable. Postoperative POP-Q measurements (Ba and C) significantly improved in the vNOTES LS group at day 1, month 6, and year 1 (<i>p</i> < 0.05). Operative time and hematocrit changes were similar (<i>p</i> > 0.05). Hospital stay was shorter with vNOTES LS (1.05 ± 0.22 vs. 2.2 ± 0.75 days, <i>p</i> < 0.05), and fewer complications were noted. No urinary injury, mesh erosion, or recurrence occurred in the vNOTES LS group.</p><p><strong>Conclusions: </strong>vNOTES LS demonstrated comparable success to LLS with shorter hospital stays and fewer complications. Its minimally invasive nature highlights its potential as a promising alternative for selected patients.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":"34 5","pages":"416-423"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of safety for self-retracting intraperitoneal device for small bowel in minimally invasive surgery. 微创手术中自收放式腹腔内装置安全性的验证。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-05-21 DOI: 10.1080/13645706.2025.2500742
Samer Abu Salem, Koby Goren, Samer Michael, Ronit Brodie, David Kushnir, Jenia Yagil, Gabriel Szydlo Shein, Brigitte Helou, Gad Marom, Yoav Mintz

Background: Modernly, abdominal surgery has shifted to minimally invasive techniques with an inclination towards fewer incisions. This has made intra-abdominal retraction more challenging. Despite development in retracting instrumentation for solid organs, the mobilization of the bowel remains challenging due to its friable nature. Therefore, there is a need to investigate the safety profile of internal retractors such as the EndoGrab for small-bowel retraction.

Methods: Twenty locations of small bowel were selected for EndoGrab retraction in two pigs. The locations were studied for iatrogenic injury at acute and delayed stages. Evaluation of injury was assessed clinically and histologically.

Results: After the EndoGrab application, no immediate signs of perforation or ischemia were observed. The clinical post-operative course was uncomplicated. Histopathology findings included serosal compression and minimal mucosal ulceration. Long-term changes showed mild changes of focal edema and fibrosis, with inter-individual variability in severity.

Conclusion: While there were no signs of overt macroscopic acute injury, minimal microscopic changes were evident. According to this small-scale study, the EndoGrab can provide an effective and safe solution for small-bowel self-retractors. More research is needed to acquire a higher level of evidence for safety. Such a solution could eliminate ports or assistants previously designed for retraction only.

背景:现代,腹部手术已经转向微创技术,倾向于更少的切口。这使得腹内回缩更具挑战性。尽管固体器官的收缩器械有所发展,但由于肠的易碎性,肠的动员仍然具有挑战性。因此,有必要研究内牵开器(如EndoGrab)用于小肠牵开的安全性。方法:选取2头猪小肠20个部位进行EndoGrab牵开。研究了急性期和延迟期医源性损伤的部位。对损伤进行临床和组织学评估。结果:EndoGrab应用后,没有立即观察到穿孔或缺血的迹象。临床术后过程简单。组织病理学结果包括浆膜压迫和轻微的粘膜溃疡。长期变化显示局灶性水肿和纤维化的轻度变化,严重程度因人而异。结论:虽然肉眼没有明显的急性损伤迹象,但显微变化明显。根据这项小规模的研究,EndoGrab可以为小肠自牵开器提供有效和安全的解决方案。需要更多的研究来获得更高水平的安全性证据。这样的解决方案可以消除以前设计的仅用于缩回的端口或辅助。
{"title":"Validation of safety for self-retracting intraperitoneal device for small bowel in minimally invasive surgery.","authors":"Samer Abu Salem, Koby Goren, Samer Michael, Ronit Brodie, David Kushnir, Jenia Yagil, Gabriel Szydlo Shein, Brigitte Helou, Gad Marom, Yoav Mintz","doi":"10.1080/13645706.2025.2500742","DOIUrl":"10.1080/13645706.2025.2500742","url":null,"abstract":"<p><strong>Background: </strong>Modernly, abdominal surgery has shifted to minimally invasive techniques with an inclination towards fewer incisions. This has made intra-abdominal retraction more challenging. Despite development in retracting instrumentation for solid organs, the mobilization of the bowel remains challenging due to its friable nature. Therefore, there is a need to investigate the safety profile of internal retractors such as the EndoGrab for small-bowel retraction.</p><p><strong>Methods: </strong>Twenty locations of small bowel were selected for EndoGrab retraction in two pigs. The locations were studied for iatrogenic injury at acute and delayed stages. Evaluation of injury was assessed clinically and histologically.</p><p><strong>Results: </strong>After the EndoGrab application, no immediate signs of perforation or ischemia were observed. The clinical post-operative course was uncomplicated. Histopathology findings included serosal compression and minimal mucosal ulceration. Long-term changes showed mild changes of focal edema and fibrosis, with inter-individual variability in severity.</p><p><strong>Conclusion: </strong>While there were no signs of overt macroscopic acute injury, minimal microscopic changes were evident. According to this small-scale study, the EndoGrab can provide an effective and safe solution for small-bowel self-retractors. More research is needed to acquire a higher level of evidence for safety. Such a solution could eliminate ports or assistants previously designed for retraction only.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"378-385"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144111365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experience with transarterial embolization for large symptomatic renal angiomyolipomas in patients with a solitary kidney: long-term outcomes. 经动脉栓塞治疗单肾患者大症状性肾血管平滑肌脂肪瘤的经验:长期结果。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-06-27 DOI: 10.1080/13645706.2025.2523257
Heng Zhang, Jin Xin Fu, Jin Long Zhang, Li Min Meng, Xi Long Yu, Mao Qiang Wang

Background: Treatment of large symptomatic renal angiomyolipomas (AMLs) in patients with a solitary kidney poses a challenge in controlling the tumor while preserving renal function. This retrospective research examines the safety and long-term effects of transarterial embolization (TAE) using iodized oil-bleomycin emulsion plus N-Butyl cyanoacrylate (NBCA) for treating large symptomatic AMLs in patients with a solitary kidney.

Methods: Over 20 years, 12 female patients, who had a solitary kidney due to a previous radical nephrectomy for AMLs, underwent TAE. Indications included symptomatic AMLs (retroperitoneal hematoma, hematuria or flank pain) and patients considered very high-risk for surgery (≥5 cm). The study evaluated adverse events (AEs), renal function changes, symptom relief, and tumor size.

Results: The median follow-up was 96 months. No significant kidney function decline was noted. Symptoms resolved completely in all patients, with the mean lesion diameter reducing from 7.2 ± 2.5 cm to 0.7 ± 0.5 cm (p < 0.01). Complete resolution (CR) of AMLs occurred in nine patients (83.3%), with no recurrence during follow-up.

Conclusions: TAE with iodized oil-bleomycin emulsion plus NBCA for treatment with large symptomatic AMLs in solitary kidney is safe and durability effect, with complete resolution of the symptoms, high rate CR of the tumors, without deterioration of the renal function.

Trial registration: ChiCTR2100053296.

背景:孤立肾患者的大症状性肾血管平滑肌脂肪瘤(AMLs)的治疗在控制肿瘤的同时保持肾功能是一个挑战。本回顾性研究探讨了碘化油-博来霉素乳剂加n -氰基丙烯酸酯丁酯(NBCA)经动脉栓塞(TAE)治疗孤立肾患者症状性大aml的安全性和长期效果。方法:在过去的20年里,12名女性患者因AMLs的根治性肾切除术而有一个孤立的肾脏,接受了TAE。适应症包括有症状的aml(腹膜后血肿、血尿或侧腹疼痛)和高危手术患者(≥5 cm)。该研究评估了不良事件(ae)、肾功能改变、症状缓解和肿瘤大小。结果:中位随访时间为96个月。肾功能未见明显下降。所有患者症状完全缓解,平均病灶直径由7.2±2.5 cm减小至0.7±0.5 cm (p)。结论:TAE联合碘化油博来霉素乳剂联合NBCA治疗孤立性肾大症状性aml,疗效安全、持久,症状完全缓解,肿瘤成形率高,无肾功能恶化。试验注册:ChiCTR2100053296。
{"title":"Experience with transarterial embolization for large symptomatic renal angiomyolipomas in patients with a solitary kidney: long-term outcomes.","authors":"Heng Zhang, Jin Xin Fu, Jin Long Zhang, Li Min Meng, Xi Long Yu, Mao Qiang Wang","doi":"10.1080/13645706.2025.2523257","DOIUrl":"10.1080/13645706.2025.2523257","url":null,"abstract":"<p><strong>Background: </strong>Treatment of large symptomatic renal angiomyolipomas (AMLs) in patients with a solitary kidney poses a challenge in controlling the tumor while preserving renal function. This retrospective research examines the safety and long-term effects of transarterial embolization (TAE) using iodized oil-bleomycin emulsion plus N-Butyl cyanoacrylate (NBCA) for treating large symptomatic AMLs in patients with a solitary kidney.</p><p><strong>Methods: </strong>Over 20 years, 12 female patients, who had a solitary kidney due to a previous radical nephrectomy for AMLs, underwent TAE. Indications included symptomatic AMLs (retroperitoneal hematoma, hematuria or flank pain) and patients considered very high-risk for surgery (≥5 cm). The study evaluated adverse events (AEs), renal function changes, symptom relief, and tumor size.</p><p><strong>Results: </strong>The median follow-up was 96 months. No significant kidney function decline was noted. Symptoms resolved completely in all patients, with the mean lesion diameter reducing from 7.2 ± 2.5 cm to 0.7 ± 0.5 cm (<i>p</i> < 0.01). Complete resolution (CR) of AMLs occurred in nine patients (83.3%), with no recurrence during follow-up.</p><p><strong>Conclusions: </strong>TAE with iodized oil-bleomycin emulsion plus NBCA for treatment with large symptomatic AMLs in solitary kidney is safe and durability effect, with complete resolution of the symptoms, high rate CR of the tumors, without deterioration of the renal function.</p><p><strong>Trial registration: </strong>ChiCTR2100053296.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"395-405"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144506524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic transvesical vesicovaginal fistula repair: technical point from a tertiary center. 机器人经膀胱膀胱阴道瘘修复:来自三级中心的技术要点。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-07-09 DOI: 10.1080/13645706.2025.2530463
Sonia Costantino, Lorenzo De Bon, Luca Roggero, Claudio Brancelli, Alberto Baielli, Francesco Ditonno, Davide Brusa, Greta Pettenuzzo, Matteo Balzarro, Emanuele Rubilotta, Antonio Benito Porcaro, Alessandro Veccia, Maria Angela Cerruto, Riccardo Bertolo, Alessandro Antonelli

Background: The aim of this study was to report the institutional experience with robot-assisted trans-vesical vesico-vaginal fistula (VVF) repair focusing on technical points.

Methods: Patients diagnosed with VVF who came to our observation between December 2020 and January 2024 were included in the analysis. Beyond computed tomography scan, all patients underwent pre-operative cystoscopy; a cystography could also be executed. All patients were scheduled for robot-assisted repair with trans-vesical approach.

Results: Five VVFs were developed after previous gynecological surgery, while one occurred after a urological surgical procedure. The median operative time was 137 min [interquartile range (IQR) (99-150)]. Intraoperative blood loss was negligible. The average hospital stay was six days. The urinary catheter was removed within four weeks (median catheterization time, 16.5 days) (IQR 14-27) after cystography was negative for leakages. One patient reported fever within three months from surgery (Clavien II). Pathology reports were negative for malignancies in all cases. No recurrences were reported during the follow-up.

Conclusions: Robotic repair of VVF with a trans-vesical approach represents a safe and effective surgical option.

背景:本研究的目的是报告机器人辅助经膀胱膀胱阴道瘘(VVF)修复的机构经验,重点是技术要点。方法:在2020年12月至2024年1月期间来我们观察的诊断为VVF的患者纳入分析。除计算机断层扫描外,所有患者术前均行膀胱镜检查;也可以进行膀胱造影。所有患者均计划采用机器人辅助的经膀胱入路修复。结果:5例发生于既往妇科手术后,1例发生于泌尿外科手术后。中位手术时间为137 min[四分位间距(IQR)(99-150)]。术中出血量可忽略不计。平均住院时间为6天。膀胱造影结果为阴性后,在4周内(中位置管时间16.5天)(IQR 14-27)拔除导尿管。1例患者术后3个月内出现发热(Clavien II)。所有病例病理报告均为恶性肿瘤。随访期间无复发报告。结论:机器人经膀胱入路修复VVF是一种安全有效的手术选择。
{"title":"Robotic transvesical vesicovaginal fistula repair: technical point from a tertiary center.","authors":"Sonia Costantino, Lorenzo De Bon, Luca Roggero, Claudio Brancelli, Alberto Baielli, Francesco Ditonno, Davide Brusa, Greta Pettenuzzo, Matteo Balzarro, Emanuele Rubilotta, Antonio Benito Porcaro, Alessandro Veccia, Maria Angela Cerruto, Riccardo Bertolo, Alessandro Antonelli","doi":"10.1080/13645706.2025.2530463","DOIUrl":"10.1080/13645706.2025.2530463","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to report the institutional experience with robot-assisted trans-vesical vesico-vaginal fistula (VVF) repair focusing on technical points.</p><p><strong>Methods: </strong>Patients diagnosed with VVF who came to our observation between December 2020 and January 2024 were included in the analysis. Beyond computed tomography scan, all patients underwent pre-operative cystoscopy; a cystography could also be executed. All patients were scheduled for robot-assisted repair with trans-vesical approach.</p><p><strong>Results: </strong>Five VVFs were developed after previous gynecological surgery, while one occurred after a urological surgical procedure. The median operative time was 137 min [interquartile range (IQR) (99-150)]. Intraoperative blood loss was negligible. The average hospital stay was six days. The urinary catheter was removed within four weeks (median catheterization time, 16.5 days) (IQR 14-27) after cystography was negative for leakages. One patient reported fever within three months from surgery (Clavien II). Pathology reports were negative for malignancies in all cases. No recurrences were reported during the follow-up.</p><p><strong>Conclusions: </strong>Robotic repair of VVF with a trans-vesical approach represents a safe and effective surgical option.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"358-364"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144591627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective study comparing EUS-BD and ERCP-BD after duodenal stent placement in patients with malignant biliary and duodenal obstruction. 一项回顾性研究比较EUS-BD和ERCP-BD在恶性胆道和十二指肠梗阻患者植入十二指肠支架后的疗效。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-07-25 DOI: 10.1080/13645706.2025.2537407
Mitsuru Sugimoto, Tadayuki Takagi, Rei Suzuki, Hiroyuki Asama, Hiroshi Shimizu, Kentaro Sato, Rei Ohira, Jun Nakamura, Mika Takasumi, Tsunetaka Kato, Takumi Yanagita, Mitsuru Otsuka, Takuto Hikichi, Hiromasa Ohira

Background: In patients with malignant biliary and duodenal obstruction (MBDO), biliary and duodenal double stenting is necessary. However, whether the time to recurrent biliary obstruction (TRBO) can be extended with ERCP-guided biliary drainage (ERCP-BD) or EUS-guided BD (EUS-BD) has not been sufficiently elucidated. Therefore, the aim of this study was to determine whether ERCP-BD or EUS-BD was more useful for increasing the TRBO with duodenal stenting.

Methods: We compared the TRBO with duodenal stenting and other clinical outcomes between ERCP-BD and EUS-BD in MBDO patients. We matched the patient characteristics of the two groups using propensity scores.

Results: Technical success was greater in the EUS-BD group (n = 17/17, 100%) than in the ERCP-BD group (n = 32/52, 61.5%) (p < 0.01). After propensity score matching, 17 matched pairs were included for further analysis. There was no significant difference in the TRBO following duodenal stenting between the ERCP-BD group (median of 62 days) and the EUS-BD group (median of 68 days) (p = 0.94).

Conclusion: The TRBO following duodenal stenting was comparable between ERCP-BD and EUS-BD. The technical success of EUS-BD was superior to that of ERCP-BD; therefore, EUS-BD might be the optimal choice for endoscopic BD in MBDO patients.

背景:在恶性胆道和十二指肠梗阻(MBDO)患者中,胆道和十二指肠双支架植入术是必要的。然而,ercp引导的胆道引流(ERCP-BD)或eus引导的BD (EUS-BD)是否可以延长复发性胆道梗阻(TRBO)的时间还没有得到充分的阐明。因此,本研究的目的是确定ERCP-BD或EUS-BD是否更有助于增加十二指肠支架植入术的TRBO。方法:比较TRBO与十二指肠支架植入术以及ERCP-BD与EUS-BD治疗MBDO患者的其他临床结果。我们使用倾向评分来匹配两组患者的特征。结果:EUS-BD组技术成功率(n = 17/17, 100%)高于ERCP-BD组(n = 32/52, 61.5%) (p = 0.94)。结论:ERCP-BD和EUS-BD十二指肠支架植入术后的TRBO具有可比性。EUS-BD的技术成功率优于ERCP-BD;因此,EUS-BD可能是MBDO患者内镜下BD的最佳选择。
{"title":"A retrospective study comparing EUS-BD and ERCP-BD after duodenal stent placement in patients with malignant biliary and duodenal obstruction.","authors":"Mitsuru Sugimoto, Tadayuki Takagi, Rei Suzuki, Hiroyuki Asama, Hiroshi Shimizu, Kentaro Sato, Rei Ohira, Jun Nakamura, Mika Takasumi, Tsunetaka Kato, Takumi Yanagita, Mitsuru Otsuka, Takuto Hikichi, Hiromasa Ohira","doi":"10.1080/13645706.2025.2537407","DOIUrl":"10.1080/13645706.2025.2537407","url":null,"abstract":"<p><strong>Background: </strong>In patients with malignant biliary and duodenal obstruction (MBDO), biliary and duodenal double stenting is necessary. However, whether the time to recurrent biliary obstruction (TRBO) can be extended with ERCP-guided biliary drainage (ERCP-BD) or EUS-guided BD (EUS-BD) has not been sufficiently elucidated. Therefore, the aim of this study was to determine whether ERCP-BD or EUS-BD was more useful for increasing the TRBO with duodenal stenting.</p><p><strong>Methods: </strong>We compared the TRBO with duodenal stenting and other clinical outcomes between ERCP-BD and EUS-BD in MBDO patients. We matched the patient characteristics of the two groups using propensity scores.</p><p><strong>Results: </strong>Technical success was greater in the EUS-BD group (<i>n</i> = 17/17, 100%) than in the ERCP-BD group (<i>n</i> = 32/52, 61.5%) (<i>p</i> < 0.01). After propensity score matching, 17 matched pairs were included for further analysis. There was no significant difference in the TRBO following duodenal stenting between the ERCP-BD group (median of 62 days) and the EUS-BD group (median of 68 days) (<i>p</i> = 0.94).</p><p><strong>Conclusion: </strong>The TRBO following duodenal stenting was comparable between ERCP-BD and EUS-BD. The technical success of EUS-BD was superior to that of ERCP-BD; therefore, EUS-BD might be the optimal choice for endoscopic BD in MBDO patients.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"424-432"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144715145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local excision of rectal neoplasia: a real-world survey of current practices and perspectives. 直肠肿瘤局部切除:当前实践和观点的现实世界调查。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-07-31 DOI: 10.1080/13645706.2025.2530451
P A Boland, P D McEntee, E Murphy, A Singaravelu, J B Tuynmann, A Arezzo, F Aigner, J P Burke, R A Cahill

Background: Advancements in transanal management of rectal tumours have improved outcomes in appropriately selected patients. However, variation exists regarding optimal perioperative investigational and surgical strategy. This survey captures current opinions and practices of surgeons managing rectal neoplasia transanally.

Methods: Electronic survey regarding theranostic approaches for the transanal management of rectal neoplasia distributed via European surgical associations' mailing lists.

Results: One hundred and thirty-four surgeons from 29 countries responded, 49%, 80% and 4.5% of whom respectively perform ≤5, ≤10, and >20 excisions/year. Transanal Minimally Invasive Surgery (TAMIS) was the most popular access method (75.4%), with rigid platforms (Transanal Endoscopic Microsurgery/Transanal Endoscopic Operation) and flexible methods being used similarly (42.5% vs. 43.3%). MRI was considered the most reliable preoperative investigation overall. Surgeons performing >10 cases/year were more likely to use submucosal (53.8% vs. 31.1%, p = 0.03) and intermuscular (38.5% vs. 14.2%, p = 0.005) planes of excision and narrow band imaging as an assessment requirement (p = 0.009) but less likely to insist on MRI (p < 0.001). Surgeons performing >5 cases/year were more likely to use multiple access methods (67.6% vs. 40.9%, p = 0.003). TAMIS users were more likely to perform full thickness and intermuscular excisions (p < 0.001) with surgeons who use flexible endoscopy more likely to use the submucosal plan (p < 0.001).

Conclusions: Various surgical and perioperative practices exist for significant rectal neoplasia with significant variance by caseload, access method, and geographical location.

背景:经肛门治疗直肠肿瘤的进展改善了适当选择患者的预后。然而,关于最佳围手术期研究和手术策略存在差异。本调查收集了目前外科医生处理经肛门直肠瘤变的观点和做法。方法:通过欧洲外科协会的邮件列表对经肛门直肠肿瘤的治疗方法进行电子调查。结果:来自29个国家的134名外科医生回应,分别为49%,80%和4.5%,分别为≤5例,≤10例和bbb20例/年。经肛门微创手术(TAMIS)是最受欢迎的进入方式(75.4%),刚性平台(经肛门内镜显微手术/经肛门内镜手术)和灵活方法的使用相似(42.5%对43.3%)。总的来说,MRI被认为是最可靠的术前检查。实施bbb10例/年的外科医生更有可能使用粘膜下(53.8%对31.1%,p = 0.03)和肌间(38.5%对14.2%,p = 0.005)切除平面和窄带成像作为评估要求(p = 0.009),但不太可能坚持使用MRI (p 5例/年更有可能使用多通道方法(67.6%对40.9%,p = 0.003)。TAMIS使用者更有可能进行全层和肌间切除(p p)。结论:对于显著性直肠肿瘤,存在多种手术和围手术期做法,且因病例量、进入方法和地理位置而有显著差异。
{"title":"Local excision of rectal neoplasia: a real-world survey of current practices and perspectives.","authors":"P A Boland, P D McEntee, E Murphy, A Singaravelu, J B Tuynmann, A Arezzo, F Aigner, J P Burke, R A Cahill","doi":"10.1080/13645706.2025.2530451","DOIUrl":"10.1080/13645706.2025.2530451","url":null,"abstract":"<p><strong>Background: </strong>Advancements in transanal management of rectal tumours have improved outcomes in appropriately selected patients. However, variation exists regarding optimal perioperative investigational and surgical strategy. This survey captures current opinions and practices of surgeons managing rectal neoplasia transanally.</p><p><strong>Methods: </strong>Electronic survey regarding theranostic approaches for the transanal management of rectal neoplasia distributed <i>via</i> European surgical associations' mailing lists.</p><p><strong>Results: </strong>One hundred and thirty-four surgeons from 29 countries responded, 49%, 80% and 4.5% of whom respectively perform ≤5, ≤10, and >20 excisions/year. Transanal Minimally Invasive Surgery (TAMIS) was the most popular access method (75.4%), with rigid platforms (Transanal Endoscopic Microsurgery/Transanal Endoscopic Operation) and flexible methods being used similarly (42.5% vs. 43.3%). MRI was considered the most reliable preoperative investigation overall. Surgeons performing >10 cases/year were more likely to use submucosal (53.8% vs. 31.1%, <i>p</i> = 0.03) and intermuscular (38.5% vs. 14.2%, <i>p</i> = 0.005) planes of excision and narrow band imaging as an assessment requirement (<i>p</i> = 0.009) but less likely to insist on MRI (<i>p</i> < 0.001). Surgeons performing >5 cases/year were more likely to use multiple access methods (67.6% vs. 40.9%, <i>p</i> = 0.003). TAMIS users were more likely to perform full thickness and intermuscular excisions (<i>p</i> < 0.001) with surgeons who use flexible endoscopy more likely to use the submucosal plan (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Various surgical and perioperative practices exist for significant rectal neoplasia with significant variance by caseload, access method, and geographical location.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"335-343"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144760510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive approach for inguinoscrotal hernia repair. A systematic literature review. 腹股沟阴囊疝微创修补术。系统的文献综述。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-06-28 DOI: 10.1080/13645706.2025.2524831
Andrea Balla, Alberto Sartori, Monica Ortenzi, Livia Bressan, Mauro Podda, Salvador Morales-Conde

Background: This systematic review reports the presently available evidence regarding the results of the minimally invasive surgery (MIS) approach for the treatment of inguinoscrotal hernias (ISHs).

Methods: After PROSPERO registration (CRD-42023493129), a search was performed in the MEDLINE, Embase, and Web of Science databases.

Results: One-thousand-fifty-two patients were included (78.3% and 21.7% underwent transabdominal preperitoneal repair [TAPP] and totally extraperitoneal repair [TEP], respectively). Twenty-one complications occurred during TAPP (2.5%), and 28 occurred during TEP (12.3%). Conversion to open surgery for TAPP procedure was reported in seven patients (0.8%). TEP procedure required conversion to TAPP in 19 patients (8.3%), and open surgery in 18 patients (7.9%) (overall conversion rate 16.2%). Postoperative complication rate was 30.1% (317 patients), with 193 after TAPP repair (23.4%) and 124 after TEP repair (54.4%) (including Clavien-Dindo I-IV). Length of hospital stay ranged between one to five days after both repairs. The overall recurrence rate was 1.6% (19 recurrences), of which 12 (1.3%) and seven (2.8%) recurrences after TAPP and TEP, respectively.

Conclusions: MIS approaches for ISH repair are technically challenging. TEP repair should be avoided in case of ISH repair, due to the high rate of postoperative complications, risk of conversion and recurrences.

背景:本系统综述报告了目前可用的关于微创手术(MIS)方法治疗腹股沟阴囊疝(ISHs)的结果的证据。方法:在PROSPERO注册(CRD-42023493129)后,在MEDLINE、Embase和Web of Science数据库中进行检索。结果:共纳入1252例患者,其中78.3%行经腹腹膜前修复术(TAPP), 21.7%行全腹膜外修复术(TEP)。TAPP期间发生并发症21例(2.5%),TEP期间发生并发症28例(12.3%)。7例患者(0.8%)报告TAPP手术转为开放手术。19例(8.3%)患者需要转换为TAPP, 18例(7.9%)患者需要开放手术(总转换率为16.2%)。术后并发症发生率为30.1%(317例),其中TAPP修复193例(23.4%),TEP修复124例(54.4%)(包括Clavien-Dindo I-IV)。两次修复后的住院时间在一到五天之间。总复发率为1.6%(19例),其中TAPP和TEP术后复发率分别为12例(1.3%)和7例(2.8%)。结论:MIS入路在ISH修复技术上具有挑战性。由于术后并发症发生率高,有转归和复发的风险,应避免在ISH修复的情况下进行TEP修复。
{"title":"Minimally invasive approach for inguinoscrotal hernia repair. A systematic literature review.","authors":"Andrea Balla, Alberto Sartori, Monica Ortenzi, Livia Bressan, Mauro Podda, Salvador Morales-Conde","doi":"10.1080/13645706.2025.2524831","DOIUrl":"10.1080/13645706.2025.2524831","url":null,"abstract":"<p><strong>Background: </strong>This systematic review reports the presently available evidence regarding the results of the minimally invasive surgery (MIS) approach for the treatment of inguinoscrotal hernias (ISHs).</p><p><strong>Methods: </strong>After PROSPERO registration (CRD-42023493129), a search was performed in the MEDLINE, Embase, and Web of Science databases.</p><p><strong>Results: </strong>One-thousand-fifty-two patients were included (78.3% and 21.7% underwent transabdominal preperitoneal repair [TAPP] and totally extraperitoneal repair [TEP], respectively). Twenty-one complications occurred during TAPP (2.5%), and 28 occurred during TEP (12.3%). Conversion to open surgery for TAPP procedure was reported in seven patients (0.8%). TEP procedure required conversion to TAPP in 19 patients (8.3%), and open surgery in 18 patients (7.9%) (overall conversion rate 16.2%). Postoperative complication rate was 30.1% (317 patients), with 193 after TAPP repair (23.4%) and 124 after TEP repair (54.4%) (including Clavien-Dindo I-IV). Length of hospital stay ranged between one to five days after both repairs. The overall recurrence rate was 1.6% (19 recurrences), of which 12 (1.3%) and seven (2.8%) recurrences after TAPP and TEP, respectively.</p><p><strong>Conclusions: </strong>MIS approaches for ISH repair are technically challenging. TEP repair should be avoided in case of ISH repair, due to the high rate of postoperative complications, risk of conversion and recurrences.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"344-357"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144528671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimized design of a non-isopeak-ring endovascular stent graft for thoracic aortic aneurysm. 胸主动脉瘤非等开环血管内支架的优化设计。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-06-24 DOI: 10.1080/13645706.2025.2523253
Yu Zhou, Chengli Song, Ailing Zhang, Shiju Yan

Background: To optimize the design of the stent graft (SG) with a non-isopeak-ring, this study investigates the radial support and bending flexibility properties of SGs with different spacing, number of peaks, and peak heights.

Methods: Numerical simulation and physical experiments were used to compare the mechanical properties of isopeak-ring SGs and non-isopeak-ring SGs.

Results: Greater spacing of stent rings can provide greater bending flexibility; fewer peaks in the stent ring result in more radial support and less spring-back force. The SG design featuring a gradient of five wave peaks and a minimum stent ring spacing of 5 mm has the best flexibility. The relationship in terms of radial support force magnitude is as follows: isopeak-ring with heights of 13 mm > combination > gradient > isopeak-ring with heights of 16 mm. Additionally, the smaller the peak height, the greater its radial support.

Conclusions: It is found that the gradient SG with five peaks not only provides sufficient radial support but also demonstrates superior flexibility compared to other types of SGs.

背景:为了优化非等峰环支架的设计,本研究研究了不同间距、峰数和峰高的支架的径向支撑和弯曲柔韧性。方法:采用数值模拟和物理实验相结合的方法,比较等丁环和非等丁环的力学性能。结果:支架环间距越大,可提供更大的弯曲灵活性;支架环的峰值越少,径向支撑越大,回弹力越小。SG设计具有5个波峰梯度和最小支架环间距5mm的特点,具有最佳的灵活性。径向支撑力大小的关系为:等高13mm的等高环>组合>梯度>等高16mm的等高环。此外,峰高越小,其径向支撑越大。结论:五峰梯度SG与其他类型SG相比,不仅具有足够的径向支持,而且具有优越的柔韧性。
{"title":"Optimized design of a non-isopeak-ring endovascular stent graft for thoracic aortic aneurysm.","authors":"Yu Zhou, Chengli Song, Ailing Zhang, Shiju Yan","doi":"10.1080/13645706.2025.2523253","DOIUrl":"10.1080/13645706.2025.2523253","url":null,"abstract":"<p><strong>Background: </strong>To optimize the design of the stent graft (SG) with a non-isopeak-ring, this study investigates the radial support and bending flexibility properties of SGs with different spacing, number of peaks, and peak heights.</p><p><strong>Methods: </strong>Numerical simulation and physical experiments were used to compare the mechanical properties of isopeak-ring SGs and non-isopeak-ring SGs.</p><p><strong>Results: </strong>Greater spacing of stent rings can provide greater bending flexibility; fewer peaks in the stent ring result in more radial support and less spring-back force. The SG design featuring a gradient of five wave peaks and a minimum stent ring spacing of 5 mm has the best flexibility. The relationship in terms of radial support force magnitude is as follows: isopeak-ring with heights of 13 mm > combination > gradient > isopeak-ring with heights of 16 mm. Additionally, the smaller the peak height, the greater its radial support.</p><p><strong>Conclusions: </strong>It is found that the gradient SG with five peaks not only provides sufficient radial support but also demonstrates superior flexibility compared to other types of SGs.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"386-394"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144475916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of embolization endpoints on the efficacy of uterine artery embolization for adenomyosis. 栓塞终点对子宫动脉栓塞治疗bb0疗效的影响。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-10-01 Epub Date: 2025-07-17 DOI: 10.1080/13645706.2025.2531204
Liang Yin, Xingwei Sun, Meijin Wu, Mingqing Zhang, Jian Jing, Xuming Bai, Yong Jin

Background: This study aimed to assess how embolization endpoints affect the efficacy of uterine artery embolization (UAE) for adenomyosis.

Methods: In this single-center retrospective cohort study, patients treated with UAE from 2014-2018 received the standard embolization endpoint (SEE), while those from 2019-2022 received the delayed embolization endpoint (DEE). Clinical outcomes, including embolic microsphere volume, uterine volume, CA125 levels, hemoglobin, menstrual flow, dysmenorrhea, and postoperative complications, were compared between the groups.

Results: At six months post-procedure, all patients showed significant improvement in clinical indicators (p < 0.01). Group DEE used significantly more embolic microspheres than Group SEE (p < 0.01) and achieved greater reductions in CA125, menstrual volume, and dysmenorrhea (p < 0.05). There were no significant differences in postoperative uterine volume, hemoglobin, or complication rates between the groups (p > 0.05).

Conclusions: UAE is a safe and effective treatment for adenomyosis. Compared to the standard approach, the delayed embolization endpoint provides superior symptom relief and warrants broader clinical adoption.

背景:本研究旨在评估栓塞终点如何影响子宫动脉栓塞(UAE)治疗子宫腺肌症的疗效。方法:在这项单中心回顾性队列研究中,2014-2018年接受UAE治疗的患者接受标准栓塞终点(SEE),而2019-2022年接受延迟栓塞终点(DEE)。比较两组患者的临床结果,包括栓塞微球体积、子宫体积、CA125水平、血红蛋白、月经流量、痛经、术后并发症。结果:术后6个月,所有患者的临床指标均有显著改善(p < 0.05)。结论:UAE是一种安全有效的治疗子宫腺肌症的方法。与标准方法相比,延迟栓塞终点提供了更好的症状缓解,值得更广泛的临床应用。
{"title":"The impact of embolization endpoints on the efficacy of uterine artery embolization for adenomyosis.","authors":"Liang Yin, Xingwei Sun, Meijin Wu, Mingqing Zhang, Jian Jing, Xuming Bai, Yong Jin","doi":"10.1080/13645706.2025.2531204","DOIUrl":"10.1080/13645706.2025.2531204","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to assess how embolization endpoints affect the efficacy of uterine artery embolization (UAE) for adenomyosis.</p><p><strong>Methods: </strong>In this single-center retrospective cohort study, patients treated with UAE from 2014-2018 received the standard embolization endpoint (SEE), while those from 2019-2022 received the delayed embolization endpoint (DEE). Clinical outcomes, including embolic microsphere volume, uterine volume, CA125 levels, hemoglobin, menstrual flow, dysmenorrhea, and postoperative complications, were compared between the groups.</p><p><strong>Results: </strong>At six months post-procedure, all patients showed significant improvement in clinical indicators (p < 0.01). Group DEE used significantly more embolic microspheres than Group SEE (p < 0.01) and achieved greater reductions in CA125, menstrual volume, and dysmenorrhea (p < 0.05). There were no significant differences in postoperative uterine volume, hemoglobin, or complication rates between the groups (p > 0.05).</p><p><strong>Conclusions: </strong>UAE is a safe and effective treatment for adenomyosis. Compared to the standard approach, the delayed embolization endpoint provides superior symptom relief and warrants broader clinical adoption.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"406-415"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144659622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of transcervical resection of polyp combined with levonorgestrel-releasing intrauterine system in the treatment of endometrial polyps: a randomized controlled trial. 经宫颈息肉切除术联合左炔诺孕酮释放宫内系统治疗子宫内膜息肉的疗效:一项随机对照试验。
IF 2 4区 医学 Q2 SURGERY Pub Date : 2025-09-02 DOI: 10.1080/13645706.2025.2542329
Yu-Jie Zhang, Xiao-Dong Wang, Mei Shan, Qing-Ling Lu, Ting-Ting Tian

Background: This study aimed to compare the clinical efficacy and prognosis of transcervical resection of polyp (TCRP) combined with levonorgestrel-releasing intrauterine system (LNG-IUS) or oral desogestrel and ethinyl estradiol tablets (DET) in patients with endometrial polyps (EMP).

Methods: A total of 100 EMP patients undergoing TCRP were divided into LNG-IUS (n = 50) and DET (n = 50) groups. Hemoglobin, endometrial thickness, FSH, E2, and LH levels were monitored pre-surgery and post-surgery. Clinical symptom improvement, adverse reactions, and recurrence rates were assessed over 12 months.

Results: Both treatments improved hemoglobin levels and reduced endometrial thickness, but the LNG-IUS group showed superior outcomes. At 12 months, it achieved higher improvement rates for dysmenorrhea (72.0% vs. 34.0%), abnormal cycles (60.0% vs. 24.0%), and blood loss (52.0% vs. 30.0%), with fewer adverse reactions (4.0% vs. 24.0%) and a lower recurrence rate (0% vs. 16.0%, all p < .05).

Conclusions: LNG-IUS with TCRP outperformed DET in reducing endometrial thickness, alleviating symptoms, lowering side effects, and preventing recurrence in EMP.

背景:本研究旨在比较经宫颈息肉切除术(TCRP)联合左炔诺孕酮释放宫内系统(LNG-IUS)或口服地沙孕酮炔雌醇片(DET)治疗子宫内膜息肉(EMP)的临床疗效和预后。方法:将100例接受TCRP治疗的EMP患者分为LNG-IUS组(n = 50)和DET组(n = 50)。术前和术后监测血红蛋白、子宫内膜厚度、卵泡刺激素、E2和LH水平。在12个月内评估临床症状改善、不良反应和复发率。结果:两种治疗均可改善血红蛋白水平,降低子宫内膜厚度,但LNG-IUS组疗效更佳。12个月时,痛经(72.0% vs. 34.0%)、月经周期异常(60.0% vs. 24.0%)、出血量(52.0% vs. 30.0%)的改善率更高,不良反应(4.0% vs. 24.0%)更少,复发率(0% vs. 16.0%)更低,均为p结论:LNG-IUS联合TCRP在减少子宫内膜厚度、减轻症状、降低副作用、预防EMP复发方面优于DET。
{"title":"Efficacy of transcervical resection of polyp combined with levonorgestrel-releasing intrauterine system in the treatment of endometrial polyps: a randomized controlled trial.","authors":"Yu-Jie Zhang, Xiao-Dong Wang, Mei Shan, Qing-Ling Lu, Ting-Ting Tian","doi":"10.1080/13645706.2025.2542329","DOIUrl":"https://doi.org/10.1080/13645706.2025.2542329","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to compare the clinical efficacy and prognosis of transcervical resection of polyp (TCRP) combined with levonorgestrel-releasing intrauterine system (LNG-IUS) or oral desogestrel and ethinyl estradiol tablets (DET) in patients with endometrial polyps (EMP).</p><p><strong>Methods: </strong>A total of 100 EMP patients undergoing TCRP were divided into LNG-IUS (<i>n</i> = 50) and DET (<i>n</i> = 50) groups. Hemoglobin, endometrial thickness, FSH, E2, and LH levels were monitored pre-surgery and post-surgery. Clinical symptom improvement, adverse reactions, and recurrence rates were assessed over 12 months.</p><p><strong>Results: </strong>Both treatments improved hemoglobin levels and reduced endometrial thickness, but the LNG-IUS group showed superior outcomes. At 12 months, it achieved higher improvement rates for dysmenorrhea (72.0% vs. 34.0%), abnormal cycles (60.0% vs. 24.0%), and blood loss (52.0% vs. 30.0%), with fewer adverse reactions (4.0% vs. 24.0%) and a lower recurrence rate (0% vs. 16.0%, all <i>p</i> < .05).</p><p><strong>Conclusions: </strong>LNG-IUS with TCRP outperformed DET in reducing endometrial thickness, alleviating symptoms, lowering side effects, and preventing recurrence in EMP.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-9"},"PeriodicalIF":2.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144960738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Minimally Invasive Therapy & Allied Technologies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1